Example: bachelor of science
New Zealand Data Sheet - Medsafe
Clozapine is associated with an increased risk of myocarditis which has, in rare cases, been fatal. The increased risk of myocarditis is greatest in the first two months of treatment.
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Protocol for the Use and Administration of Clozapine
www.wales.nhs.ukStatus: Guideline Issue date: 30/01/2014 Revised: July 2015 Approved by: ABUHB Mental Health D+T Review by date: 30/01/2017 2. Using Clozapine for Treatment Resistant Schizophrenia Clozapine is indicated in the UK for treatment-resistant schizophrenia and for psychosis in
IMPORTANT DRUG WARNING - Clozapine REMS
www.clozapinerems.comIMPORTANT DRUG WARNING Regarding Clozapine-Containing Products Indications and Important Selected Safety Information About Clozapine-Containing Products
Clozapine: Treat the Patient or Treat the Level?
www.rcpsych.ac.ukClozapine • Effective drug, but very toxic unless used carefullyEffective drug, but very toxic unless used carefully • Extremely dangerous in clozapine-naïve subject (()cautious dose titration) • Idiosyncratic toxicity (bone marrow, heart, liver, etc.) • Narrow range of plasma concentrations associated withNarrow range of plasma concentrations associated with
Clozapine - Simply Psychiatry
www.simplypsychiatry.co.ukClozapine Clozapine is used to treat schizophrenia in patients when other medicinse have not worked. It belongs to the group of antipsychotics called the atypical antipsychotics,
HIGHLIGHTS OF PRESCRIBING INFORMATION Metabolic …
pp.jazzpharma.com1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FAZACLO safely and effectively. See full prescribing information for
ANTIPSYCHOTIC COMPARISON CHART - DBSA San Diego
www.dbsasandiego.orgANTIPSYCHOTICS: Frequently asked Questions. 1. What is the difference in WEIGHT GAIN among the different antipsychotics?1 Estimated weight change at